Andreas Albertsen
@andreasalbertsen.bsky.social
Associate professor, Political Science @AarhusUni and @CEPDISCresearch. Distributive justice, controversial markets, discrimination, and organ donation ethics.
Yes, I am deleting references for an article type that only allows 10.
November 27, 2025 at 7:10 PM
Yes, I am deleting references for an article type that only allows 10.
Please let it die already! My inobox is dying
November 13, 2025 at 8:42 AM
Please let it die already! My inobox is dying
So happy to see this published. Worked away on this with Anna Dorf and Lasse Nielsen. Lots of delays and challenges. Learned so much from the qualitative work involved here.
link.springer.com/article/10.1...
link.springer.com/article/10.1...
Priority-Setting and Values: A Qualitative Study of the Danish Medicines Council - Journal of Bioethical Inquiry
As priority setting committees become commonplace in contemporary welfare states, it becomes increasingly important to understand how they operate. This article contributes to our understanding of con...
link.springer.com
November 5, 2025 at 12:43 PM
So happy to see this published. Worked away on this with Anna Dorf and Lasse Nielsen. Lots of delays and challenges. Learned so much from the qualitative work involved here.
link.springer.com/article/10.1...
link.springer.com/article/10.1...
🎯 The result:
Priority setting becomes not just a technical task, but a moral one. Evidence, uncertainty, and values intertwine.
Priority setting becomes not just a technical task, but a moral one. Evidence, uncertainty, and values intertwine.
November 5, 2025 at 12:43 PM
🎯 The result:
Priority setting becomes not just a technical task, but a moral one. Evidence, uncertainty, and values intertwine.
Priority setting becomes not just a technical task, but a moral one. Evidence, uncertainty, and values intertwine.
3️⃣ Uncertainty opens moral questions.
When evidence is uncertain, factors like patient age or disease rarity influence judgments — even though DMC isn’t designed to make ethical calls.
When evidence is uncertain, factors like patient age or disease rarity influence judgments — even though DMC isn’t designed to make ethical calls.
November 5, 2025 at 12:43 PM
3️⃣ Uncertainty opens moral questions.
When evidence is uncertain, factors like patient age or disease rarity influence judgments — even though DMC isn’t designed to make ethical calls.
When evidence is uncertain, factors like patient age or disease rarity influence judgments — even though DMC isn’t designed to make ethical calls.
2️⃣ But data are often weak.
Members describe limited documentation and poor data quality — forcing them to estimate effects rather than rely on firm evidence.
Members describe limited documentation and poor data quality — forcing them to estimate effects rather than rely on firm evidence.
November 5, 2025 at 12:43 PM
2️⃣ But data are often weak.
Members describe limited documentation and poor data quality — forcing them to estimate effects rather than rely on firm evidence.
Members describe limited documentation and poor data quality — forcing them to estimate effects rather than rely on firm evidence.
1️⃣ Effect is a core concern.
Discussions of a medicine’s health effect dominate DMC deliberations. Other concerns (like cost or fairness) rarely shape the final recommendation.
Discussions of a medicine’s health effect dominate DMC deliberations. Other concerns (like cost or fairness) rarely shape the final recommendation.
November 5, 2025 at 12:43 PM
1️⃣ Effect is a core concern.
Discussions of a medicine’s health effect dominate DMC deliberations. Other concerns (like cost or fairness) rarely shape the final recommendation.
Discussions of a medicine’s health effect dominate DMC deliberations. Other concerns (like cost or fairness) rarely shape the final recommendation.
Soon I’ll do a thread in the coming days, sharing links to publications, etc. There is a lot to share :-)
October 29, 2025 at 6:08 PM
Soon I’ll do a thread in the coming days, sharing links to publications, etc. There is a lot to share :-)
Link to the paper here. It is open access
link.springer.com/article/10.1...
#bioethics #discrimination #disability #disabilitydiscrimination #healthcarerationing
link.springer.com/article/10.1...
#bioethics #discrimination #disability #disabilitydiscrimination #healthcarerationing
The Moral Justifications of Disability Discrimination in Health Care Allocation: An Experimental Assessment - Health Care Analysis
Cost-effectiveness analysis (CEA) is a mainstay of contemporary health care priority setting. However, priority setting in reference to cost-effectiveness may discriminate against people with disabilities. The ethical literature on priority setting suggests that the permissibility of such discrimination varies with the reason why people with disabilities receive lower priority. In a vignette-based survey experiment (N = 1100) in the UK, we tested whether five justifications for prioritizing people without disabilities affect the views of the broader public on priority setting based on CEA. In our vignettes, a hospital denies a person with a disability treatment for a disease based on CEA, and respondents were asked to assess the moral permissibility of this. The vignettes varied in terms of the reason the hospital emphasized in the decision. We tested vignettes emphasizing lower expected lifespan, lower quality of life, higher costs of treatment due to disability, less efficient treatment due to disability, and lower productivity due to infrequent labor-market participation. Our study is an initial exploratory survey experiment, exploring participant’s responses to CEA with respect to disability. Discrimination against the patient with a disability was deemed impermissible across all experimental conditions, and there were no significant differences between the various reasons. This suggests a discrepancy between folk intuitions and those of many ethicists.
link.springer.com
October 2, 2025 at 5:20 PM
Link to the paper here. It is open access
link.springer.com/article/10.1...
#bioethics #discrimination #disability #disabilitydiscrimination #healthcarerationing
link.springer.com/article/10.1...
#bioethics #discrimination #disability #disabilitydiscrimination #healthcarerationing
This contrasts with the ethical literature, where much debate turns on which reason might justify prioritizing non-disabled patients.
October 2, 2025 at 5:20 PM
This contrasts with the ethical literature, where much debate turns on which reason might justify prioritizing non-disabled patients.
Across all scenarios, respondents judged the discrimination as impermissible.
There were no significant differences between the reasons for treatment not being cost-effective.
There were no significant differences between the reasons for treatment not being cost-effective.
October 2, 2025 at 5:20 PM
Across all scenarios, respondents judged the discrimination as impermissible.
There were no significant differences between the reasons for treatment not being cost-effective.
There were no significant differences between the reasons for treatment not being cost-effective.
We varied why treatment for the person with a disability was less cost-effective:
– shorter expected lifespan
– lower quality of life
– higher treatment costs
– lower treatment efficiency
– reduced productivity
– shorter expected lifespan
– lower quality of life
– higher treatment costs
– lower treatment efficiency
– reduced productivity
October 2, 2025 at 5:20 PM
We varied why treatment for the person with a disability was less cost-effective:
– shorter expected lifespan
– lower quality of life
– higher treatment costs
– lower treatment efficiency
– reduced productivity
– shorter expected lifespan
– lower quality of life
– higher treatment costs
– lower treatment efficiency
– reduced productivity